Related Experiment Video
Updated: May 21, 2025

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Peli1, regulated by m6A modification, suppresses NLRP3 inflammasome activation in atherosclerosis by inhibiting YB-1
Qiang Liu1,2, Lu Yan1, Tao Wu1
1Department of Cardiovascular Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Abstract:
The activation of pyrin domain-containing-3 (NLRP3) inflammasome in macrophages is a risk factor accelerating the progression of atherosclerosis (AS). Here, the function of pellino 1 (Peli1) in regulating the activation of NLRP3 inflammasome during the development of AS was investigated. Our results showed that Y-box binding protein 1 (YB-1) knockdown could inhibit the progression of AS in vivo, and YB-1 silencing repressed oxidized low-density lipoprotein (ox-LDL)-mediated lipid accumulation and inflammation in macrophages by inactivating NLRP3 inflammasome. E3 ubiquitination ligase Peli1 mediated ubiquitination-dependent degradation of YB-1 during AS progression. Moreover, it was found that YTH domain-containing 2 (YTHDC2) recognized methyltransferase-like 3 (METTL3)-mediated Peli1 N6-methyladenosine (m6A) modification and mediated Peli1 mRNA degradation. Rescue studies revealed that YB-1 upregulation abrogated the repressive effect of Peli1 upregulation on AS progression both in vitro and in vivo. Taken together, Peli1, regulated by m6A modification, inhibited YB-1-mediated activation of NLRP3 inflammasome in macrophages by promoting YB-1 ubiquitination to suppress the progression of AS.
Insights
Pellino 1 (Peli1) suppresses atherosclerosis by targeting Y-box binding protein 1 (YB-1). Peli1 promotes YB-1 degradation, inhibiting NLRP3 inflammasome activation and AS progression.
Area of Science:
- Biochemistry
- Immunology
- Molecular Biology
Background:
- The NLRP3 inflammasome in macrophages accelerates atherosclerosis (AS) progression.
- Understanding regulators of NLRP3 inflammasome activation in AS is crucial.
Purpose of the Study:
- To investigate the role of Pellino 1 (Peli1) in regulating NLRP3 inflammasome activation during AS development.
- To elucidate the molecular mechanisms by which Peli1 influences AS progression.
Main Methods:
- In vivo and in vitro studies using YB-1 knockdown and Peli1 manipulation.
- Assessment of lipid accumulation and inflammation in macrophages.
- Investigation of ubiquitination, N6-methyladenosine (m6A) modification, and mRNA degradation pathways.
Main Results:
- YB-1 knockdown inhibited AS progression, reducing ox-LDL-induced lipid accumulation and inflammation by inactivating NLRP3 inflammasome.
- Peli1 mediated ubiquitination-dependent degradation of YB-1.
- YTHDC2 recognized METTL3-mediated Peli1 m6A modification, leading to Peli1 mRNA degradation.
- YB-1 upregulation counteracted the protective effects of Peli1 upregulation on AS.
Conclusions:
- Peli1, regulated by m6A modification, suppresses AS progression.
- Peli1 inhibits YB-1-mediated NLRP3 inflammasome activation in macrophages via promoting YB-1 ubiquitination.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Regulation of Nuclear Protein Sorting
Abnormal Proliferation
Regulation of Expression at Multiple Steps
Master Transcription Regulators
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

